| Pharmaceutical active ingredients: |
| Agalsidase Beta |
| Available forms, composition and doses of Fabrazyme: |
| Injectable; Injection; Agalsidase Beta 35 mgInjectable; Injection; Agalsidase Beta 5 mg |
| Fabrazyme medical category: |
| Human:Enzymes |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A16AB04 - Agalsidase Beta |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GenzymeDKSH |
| Related documents and information about Fabrazyme: |
| Fabrazyme prescribing information (PDF) |